PIG Stock Chart & Stats
€9.56
-€0.14(-0.58%)
At close: 4:00 PM EST
€9.56
-€0.14(-0.58%)
Day’s Range― - ―
52-Week Range€7.82 - €24.22
Previous CloseN/A
Volume0.00
Average Volume (3M)0.00
Market Cap
€1.27B
Enterprise Value€4.85B
Total Cash (Recent Filing)€357.20M
Total Debt (Recent Filing)€3.81B
Price to Earnings (P/E)―
Beta1.00
Next Earnings
Aug 12, 2026EPS Estimate
0.3Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-13.11
Shares Outstanding138,367,770
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)0.66
Price to Sales (P/S)0.45
P/FCF Ratio13.29
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€14.90Price Target Upside55.91% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
EPS Forecast (FY)1.83
Revenue Forecast (FY)€3.51B
Bulls Say, Bears Say
Bulls Say
U.S. Store‑brand OTC Market Share GainsSustained share gains in U.S. private‑label OTC demonstrate durable commercial strength with large retailers and effective demand generation. Greater household penetration drives recurring wholesale volume and supports scale advantages in manufacturing and category pricing over the next several quarters.
Positive Operating And Free Cash FlowPositive operating and free cash flow, even while accounting profits are negative, indicate the business still converts sales into cash. This cash generation provides a tangible buffer to service obligations, fund working capital and support transformation efforts while profit recovery occurs.
Operational Savings And Portfolio Monetization To Reduce LeverageA concrete cost‑savings program plus a sizable divestiture proceeds both improve structural cash flow and capital allocation flexibility. Realized savings and monetization reduce leverage long term, free capital for reinvestment, and strengthen the balance sheet if execution stays on plan.
Bears Say
Declining Revenue And ProfitabilityMulti‑period revenue declines and a deep TTM net loss reflect soft end‑market demand and margin pressure in core categories. Persistent top‑line contraction reduces operating leverage, undermines earnings stability and makes margin recovery harder without sustained commercial improvement.
Elevated Leverage And Weakened Balance SheetHigh absolute debt with eroding equity heightens refinancing, interest and covenant risk. Limited balance sheet headroom constrains investment and M&A optionality, and makes the company more sensitive to cash flow volatility until debt is meaningfully reduced.
Margin Compression, Goodwill Hit And Cash Flow PressureMaterial margin erosion, a large noncash goodwill impairment and near‑term operating cash outflows signal both structural and cyclical stress. Together these reduce reported equity, weaken profitability metrics and limit the company's ability to self‑fund strategic investments until margins and cash cycles stabilize.
Perrigo Company News
PIG FAQ
What was Perrigo Company’s price range in the past 12 months?
Perrigo Company lowest stock price was €7.82 and its highest was €24.22 in the past 12 months.
What is Perrigo Company’s market cap?
Perrigo Company’s market cap is €1.27B.
When is Perrigo Company’s upcoming earnings report date?
Perrigo Company’s upcoming earnings report date is Aug 12, 2026 which is in 33 days.
How were Perrigo Company’s earnings last quarter?
Perrigo Company released its earnings results on May 06, 2026. The company reported €0.376 earnings per share for the quarter, beating the consensus estimate of €0.269 by €0.108.
Is Perrigo Company overvalued?
According to Wall Street analysts Perrigo Company’s price is currently Undervalued.
Does Perrigo Company pay dividends?
Perrigo Company does not currently pay dividends.
What is Perrigo Company’s EPS estimate?
Perrigo Company’s EPS estimate is 0.3.
How many shares outstanding does Perrigo Company have?
Perrigo Company has 138,367,770 shares outstanding.
What happened to Perrigo Company’s price movement after its last earnings report?
Perrigo Company reported an EPS of €0.376 in its last earnings report, beating expectations of €0.269. Following the earnings report the stock price went up 8.242%.
Which hedge fund is a major shareholder of Perrigo Company?
Currently, no hedge funds are holding shares in DE:PIG
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Perrigo Company Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
€14.90 (55.91% Upside)
€14.90 (55.91% Upside)
Blogger Sentiment
Bullish
DE:PIG Sentiment 70%
Sector Average 69%
Sector Average 69%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-57.92%
12-Months-Change
Fundamentals
Return on Equity
-50.65%
Trailing 12-Months
Asset Growth
-18.20%
Trailing 12-Months
Company Description
Perrigo Company
Perrigo Company plc provides over-the-counter health and wellness solutions in the United States, Europe, and internationally. The company operates through Consumer Self-Care Americas and Consumer Self-Care International segments. It offers upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and oral electrolyte beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers. The company also offers healthy lifestyle products, such as smoking cessation and well-being products; skin care products consisting of dermatological care, scar management, lice treatment, and other products for various skin conditions; women’s health products comprising feminine hygiene and contraceptives; vitamins, minerals, and supplements; and other miscellaneous self-care products. It sells its products under the Compeed, Dr. Fresh, Firefly, Good Sense, Good Start, Mederma, Nasonex, Plackers, Prevacid24HR, REACH, Rembrandt, Steripod, Opill, Solpadeine, Coldrex, Physiomer, NiQuitin, ACO, ellaOne, and Compeed brands. The company also offers contract manufacturing services. It sells its products through retail drug, supermarket, and mass merchandise chains; e-commerce stores; wholesalers; pharmacies; drug and grocery retailers; and para-pharmacies. The company was formerly known as Perrigo Company and changed its name to Perrigo Company plc in December 2013. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.
PIG Company Deck
PIG Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Neutral
The call presented a mixed picture: clear operational and commercial progress (market share gains, meaningful cost-savings program, completion of a divestiture and reaffirmed guidance) contrasted with material near-term revenue and margin headwinds (notably CORE net sales down ~8.3% YoY, gross/operating margin compression, a $331M goodwill impairment and cash flow pressure). Management emphasized these headwinds are largely transitory and the majority of growth and margin recovery is expected in the second half of 2026, supported by innovation, demand generation and operational improvements.View all DE:PIG earnings summariesPIG Stock 12 Month Forecast
All Analysts
Top Analysts
Average Price Target
€14.90
▲(55.91% Upside)
Technical Analysis
1 Day
3 Days
1 Week
1 Month
Viatris
―
Supernus Pharmaceuticals
―
Teva Pharmaceutical
―
Indivior
―
Amneal Pharmaceuticals
―
Options Prices
Currently, No data available
---









